At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 121 enrolled
Drug / intervention
Investigational Lubricating Eye Drop in a Novelia® bottle +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
In Brief
A Phase 2 clinical trial evaluating Investigational Lubricating Eye Drop in a Novelia® bottle and Blink® Tears eye Drops for Dry Eye. Completed, enrolled 121 participants across 8 sites.
Detailed Summary
This is a 30-Day, multi-site, single-masked, bilateral, active- controlled, 2-Arm parallel group study to evaluate the safety and efficacy of an Investigational product.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2023202420252026
First PostedDec 2022
Enrollment StartFeb 2023
Primary CompletionApr 2023
TodayJul 2026
First PostedDec 22, 2022
Enrollment StartFeb 23, 2023
Primary CompletionApr 27, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.5 years ago
Interventions
Investigational Lubricating Eye Drop in a Novelia® bottledrug
Investigational Product
Blink® Tears eye Dropsdrug
Control Product